Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis

Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis

Objective: to study the comparative efficacy of the genetically engineered biological agents infliximab (INF) and adalimumab (ADA) in patients with ankylosing spondylitis (AS). Subjects and methods. The study included 86 patients with active AS who had failed to achieve remission with the maximal to...

Full description

Saved in:
Bibliographic Details
Main Authors: Tatyana Valentinovna Mezenova, V P Tyurin, S Yu Davidyan, N A Kiryukhina, A V Elonakov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2012-04-01
Series:Научно-практическая ревматология
Subjects:
ankylosing spondylitis
infliximab
adalimumab
Online Access:https://rsp.mediar-press.net/rsp/article/view/1163
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items